首页> 外文期刊>Pathology Research and Practice >Case report of three EGFR TKI naive lung adenocarcinoma containing double EGFR mutations (L858R/T790M or Exon 19 Deletion/T790M); Comparing genetic information and histology
【24h】

Case report of three EGFR TKI naive lung adenocarcinoma containing double EGFR mutations (L858R/T790M or Exon 19 Deletion/T790M); Comparing genetic information and histology

机译:含有双EGFR突变的三种EGFR TKI幼稚肺腺癌的病例报告(L858R / T790M或EXON 19删除/ T790M); 比较遗传信息和组织学

获取原文
获取原文并翻译 | 示例
           

摘要

EGFR T790M mutation is a crucial gene alteration causing EGFR TKI resistance. However, the implication of T790M mutation is still unknown for the stepwise progression of EGFR TKI naive lung adenocarcinoma. In this study, we studied site-related EGFR T790M mutation analysis in EGFR TM nave lung adenocarcinomas harboring double EGFR mutation (L858R and T790M or Exon 19 deletion (Del.19) and T790M) by droplet digital (dd) PCR method. We examined three resected lung adenocarcinoma cases harboring EGFR double mutation including T790M. These cases didn't receive EGFR TM treatment. We divided formalin-fixed and paraffin embedded (FFPE) unstained slide tissues into 11-18 areas in each tumor and extracted DNAs from each area separately. The DNAs were analyzed by ddPCR. T790M mutation ratio (T790M/L858R or 1790M/Del.19) were calculated. For three cases, we also performed EGFR FISH for analyzing EGFR copy number. In Case 2 and 3, T790M mutation ratio were 100% and 30% homogeneously and showed increased EGFR copy number also homogeneously. However, in case 1, it was different between invasive and non-invasive areas. EGFR copy number was also heterogeneous and showed increasing only in invasive area. We indicated a peculiar case harboring T790M heterogeneity and only invasive area had T790M mutation even though the case was not treated by EGFR TM. It suggests that T790M is possibly significant not only for EGFR TM resistance but also the progression in lung adenocarcinoma.
机译:EGFR T790M突变是导致EGFR TKI抗性的至关重要的基因改变。然而,对于EGFR TKI幼稚肺腺癌的逐步进展,T790M突变的含义仍然是未知的。在本研究中,通过液滴数字(DD)PCR方法,研究了EGFR TM NAVE肺腺癌(L858R和T790M或EXON 19删除(Del.19)和T790M)的EGFR TM Nave肺腺癌中的网站相关的EGFR T790M突变分析。我们检查了含有EGFR双突变的三种切除的肺腺癌病例,包括T790M。这些病例没有收到EGFR TM治疗。我们将福尔马林固定和石蜡嵌入(FFPE)未染色的载玻片组织分为11-18个区域,并分别从每个区域提取DNA。 DDPCR分析DNA。计算T790M突变率(T790M / L858R或1790M / DEL.19)。对于三种情况,我们还进行了EGFR鱼用于分析EGFR拷贝数。在情况2和3中,T790M突变率为100%和30%均匀性,并且显示出增加的EGFR拷贝数也均匀地。但是,在案例1中,它在侵入性和非侵入性区域之间存在不同。 EGFR拷贝数也是异质的,仅在侵入区域增加。我们表示奇形的案例,含有T790M的异质性,即使壳体未通过EGFR TM治疗情况,唯一的侵入性区域也具有T790M突变。它表明T790M不仅对EGFR TM电阻而且可能显着,而且可能是肺腺癌的进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号